The impact of COVID-19 on oncology professionals: Initial results of the ESMO resilience task force survey collaboration
Authors
Banerjee, S.Lim, Kok Haw Jonathan
Kamposioras, Konstantinos
Murali, K.
Oing, C.
Punie, K.
O'Connor, M.
Devnani, B.
Lambertini, M.
Westphalen, C. B.
Lopez, P. G.
Amaral, T. M. S.
Thorne, E.
Morgan, G.
Haanen, J.
Hardy, C.
Affiliation
Gynaecology Department, Royal Marsden Hospital NHS Foundation Trust and Institute of Cancer Research, London, UK;Issue Date
2020
Metadata
Show full item recordAbstract
Background: The impact of the COVID-19 (CV-19) pandemic on wellbeing has the potential for serious negative consequences on work, home life and patient care. The ESMO Resilience Task Force collaboration set out to investigate wellbeing in oncology over time since CV-19. Methods: 2 online surveys were conducted (survey I April/May; survey II July/August 2020). Statistical analyses were used to examine group differences, associations and to explore predictors of key outcomes: 1) wellbeing/distress (Wellbeing Index (WBI- 9)), 2) burnout (1 item); and 3) CV-19 job performance (2 item CJP; standard of care and job delivery compared to pre-CV 19). Results: Survey I had 1520 participants from 101 countries. Responses indicate that CV-19 is impacting the oncology workforce resulting in a number of changes to work and personal lives. 25% were at risk of distress (poor wellbeing, WBI 4); 38% reported feeling burnout and 66% were not able to perform their job compared to pre- CV-19. Higher CJP was significantly associated with better wellbeing and not feeling burnout (p<0.01). Differences were seen in wellbeing and CJP between countries (p<0.001) and related to CV-19 country mortality rate (p<0.05). The main predictors of wellbeing, burnout and CJP were resilience and changes to work hours. Others frequently identified were coping strategies, ethnicity, concern about training/career, worried about current wellbeing, and working conditions. In Survey II, results from 942 participants are undergoing analysis. Overall, comparisons between surveys show overall wellbeing and burnout rates have worsened overtime but CJP has improved. Among 272 participants who completed both surveys, WBI scores 4 (indicating higher risk of distress) and burnout rates were higher in survey II compared to survey I (22% vs 31% p¼0.01; 35% vs 49% p=0.001 respectively) suggesting wellbeing and burnout may be worsening overtime. CJP improved (38% vs 54% p<0.001). Conclusions: In the largest global survey series, COVID-19 is impacting on the wellbeing and job performance of oncology professionals. Risk of distress and burnout has increased over time. Urgent measures to address wellbeing and improve resilience are essential.Citation
Banerjee S, Lim KHJ, Kamposioras KV, Murali K, Oing C, Punie K, et al. LBA70_PR The impact of COVID-19 on oncology professionals: Initial results of the ESMO resilience task force survey collaboration. Annals of Oncology. 2020;31:S1200-S1.Journal
Annals of OncologyDOI
10.1016/j.annonc.2020.08.2311Additional Links
https://dx.doi.org/10.1016/j.annonc.2020.08.2311Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.annonc.2020.08.2311